Robust methods to improve efficiency and reduce bias in estimating survival curves in randomized clinical trials

DOI10.1007/S10985-014-9291-YMaRDI QIDQ746638zbMATH OpenOpenAlexWikidataFDO

Authors Min Zhang

Publication date 16 October 2015

Published in Lifetime Data Analysis (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1007/s10985-014-9291-y

zbMATH Keywords

covariate-adjustmentcumulative hazard functionKaplan-Meier curveNelson-Aalen estimatortime-to-event

Mathematics Subject Classification ID

Estimation in survival analysis and censored data (62N02) Reliability and life testing (62N05) Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)

Recommendations

• Robustness of estimation methods in a survival cure model with mismeasured covariates
• Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards
• Robust and efficient parametric estimation for censored survival data
• Robust inference in discrete hazard models for randomized clinical trials
• Robust Tests for Treatment Effect in Survival Analysis under Covariate-Adaptive Randomization
• Optimal Estimator for the Survival Distribution and Related Quantities for Treatment Policies in Two‐Stage Randomization Designs in Clinical Trials
• Model robust designs for survival trials
• Semiparametric efficient estimation of survival distributions in two-stage randomisation designs in clinical trials with censored data
• Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials

Cites work

• Asymptotic Statistics
• scientific article; zbMATH DE number 1834429 (Why is no real title available?)
• scientific article; zbMATH DE number 3336465 (Why is no real title available?)
• Improving Efficiency of Inferences in Randomized Clinical Trials Using Auxiliary Covariates
• Introduction to empirical processes and semiparametric inference
• NONPARAMETRIC ANALYSIS OF COVARIANCE FOR HYPOTHESIS TESTING WITH LOGRANK AND WILCOXON SCORES AND SURVIVAL-RATE ESTIMATION IN A RANDOMIZED CLINICAL TRIAL
• Nonparametric Estimation from Incomplete Observations
• Semiparametric Estimation of Treatment Effect in a Pretest‐Posttest Study

Cited in

(13)

• Robustness of estimation methods in a survival cure model with mismeasured covariates
• Correction to: Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards
• Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards
• Landmark estimation of survival and treatment effects in observational studies
• Comment: Inference after covariate-adaptive randomisation: aspects of methodology and theory
• Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes
• Model-Robust Inference for Clinical Trials that Improve Precision by Stratified Randomization and Covariate Adjustment
• Statistical inference for data-adaptive doubly robust estimators with survival outcomes
• Sample size calculation for the augmented logrank test in randomized clinical trials
• Combining covariate adjustment with group sequential, information-adaptive designs to improve randomized trial efficiency
• On sample size determination for augmented tests based on restricted mean survival time in randomized clinical trials
• Improve efficiency and reduce bias of Cox regression models for two-stage randomization designs using auxiliary covariates
• Optimising precision and power by machine learning in randomised trials with ordinal and time-to-event outcomes with an application to COVID-19

This page was built for publication: Robust methods to improve efficiency and reduce bias in estimating survival curves in randomized clinical trials

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q746638)